Skip to content
Just-Evotec Biologics
Just-Evotec BiologicsJust-Evotec Biologics
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec
Search:
  • About
    • Our Story
    • Leadership
    • Partnership
  • GMP MANUFACTURING
  • Solutions
    • J.DESIGN
      • Humanoid Antibody Library (J.HAL)
      • GMP Manufacturing (J.POD)
  • News & Insights
    • Events
    • Press
    • Publications
      • Drug Discovery Update (DDup) journal
      • Technological insights
      • Scientific journals
      • Trade journals
    • Posters
    • Webinars
    • White Papers & Application Notes
  • Careers
  • Contact
  • Evotec

Daily Archives: September 15, 2021

Evotec publishes DDup 11 – AI-driven antibody discovery at Evotec

Scientific journalsSeptember 15, 2021

The 11th edition is dedicated to our exciting new capabilities in the biologics lane of Evotec’s “Multi-modality Autobahn.” For the biologics industry, Evotec provides a…

Learn more
Introduction to antibodies

Introduction to Antibodies

DDup 11September 15, 2021

What are antibodies? Antibodies, or immunoglobulin molecules, are glycoproteins produced by the plasma B cells of the adaptive immune system with the aim to recognise…

Learn more
AI-driven antibody discovery

AI-driven antibody discovery at Evotec

DDup 11September 15, 2021

Antibody discovery may be driven by the interrogation of two primary sources: (1) in vivo (animal-derived B cells) or (2) in vitro (library-derived antibody display…

Learn more
FFmab

Function-focused antibody (FFmab) screening

DDup 11September 15, 2021

What is FFmab screening? FFmab screening is a platform for identifying novel functional antibodies that change disease-modifying phenotypes of immune cells. The platform identifies innovative…

Learn more
Karen Lackey and Jim Thomas

Interview with Dr Jim Thomas and Karen Lackey

DDup 11September 15, 2021

What role do Biologics play in the context of novel therapeutics? Jim: Biologics are a significant and growing portion of the arsenal of therapeutics used…

Learn more
Barbara Bachler-Konetzki

Interview with Barbara Bachler-Konetzki about Evotec’s integrated antibody discovery capabilities

DDup 11September 15, 2021

What were the limitations of previous hybridoma-based approaches? Although the development of the hybridoma technology was a landmark event, the methodology still faced the limitation…

Learn more
Randall Ketchem

Interview with RANDAL R. KETCHEM about the optimization of antibodies

DDup 11September 15, 2021

How does optimization of antibodies improve development? Just – Evotec Biologics has developed a molecular optimisation platform for monoclonal antibodies to increase productivity, eliminate potential…

Learn more
innovation by design
North America
Just – Evotec Biologics, Inc.
401 Terry Avenue
Seattle, WA 98109
+1 206-651-5094
Europe + International
Just – Evotec Biologics
Business Development
info@evotec.com

Find us on:

Twitter page opens in new windowLinkedin page opens in new windowMail page opens in new window
© 2023 Just – Evotec Biologics
  • Contact
  • Imprint
  • Privacy Policy
  • Legal notice
footer menu
Go to Top
  • Ask an expert
  • Tweet
  • Share
  • Email
  • Scroll to top
  • Ask an expert
  • Twitter
  • Linkedin
  • Email
  • Whatsapp